K110313 is an FDA 510(k) clearance for the TINA-QUANT HBA1C GEN.2. This device is classified as a Assay, Glycosylated Hemoglobin (Class II - Special Controls, product code LCP).
Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on December 23, 2011, 324 days after receiving the submission on February 2, 2011.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K110313 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 02, 2011 |
| Decision Date | December 23, 2011 |
| Days to Decision | 324 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LCP — Assay, Glycosylated Hemoglobin |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 864.7470 |